Top Markets
#1 Zora Zora +31.09%
#2 Tutorial Tutorial +28.83%
#3 GALA GALA +25.38%
#4 Fabric Protocol Fabric Protocol +24.31%
#5 Pieverse Pieverse +23.14%
#6 Arowana Arowana +22.11%
#7 Derive Derive +21.73%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +20.51%
#9 Bitcoin Cash Bitcoin Cash +20.00%
#10 wojak wojak +19.94%
Coin of the day
Zora Zora
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Orexo AB Orexo AB

Orexo AB

ORX
Rangering i aksjer #24896
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Aksjekurs
$1.58
Markedsverdi
$55.40M
Endring (1 dag)
0.71%
Endring (1 år)
-28.43%
Land
SE
Handel Orexo AB (ORX)

Kategori

Healthcare
P/S-forhold for Orexo AB (ORX)
P/S-forhold per 2026 TTM: 0
Ifølge Orexo AB sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Orexo AB fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.29 -
HK